Higher doses of radiotherapy control localized prostate cancer (PCa) more effectively than lower doses 10 years after treatment and reduced the need for follow-up androgen-deprivation therapy, according to investigators.
Higher doses of radiotherapy control localized prostate cancer (PCa) more effectively than lower doses 10 years after treatment and reduced the need for follow-up androgen-deprivation therapy, according to investigators.